Flaggemelding
Hawkeye Invest AS, et selskap som kontrolleres av Øystein Barmen, har i dag solgt 2 000 000 aksjer i PCI Biotech Holding ASA. Etter handelen eier Hawkeye Invest AS ingen aksjer i PCI Biotech Holdin...
What are the potential catalysts or risks that could influence PCI Biotech’s performance after this insider sell‑off?
How might the sale of 2 million shares affect PCI Biotech’s short‑term liquidity, share float, and price volatility?
Why did Hawkeye Invest decide to sell its entire stake in PCI Biotech Holding, and what does this signal about the company's prospects?
24 days ago